{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["LKB1/AMPK/mTOR signaling pathway", "fecal microbiota transplantation", "ginsenoside Rg5", "nonalcoholic fatty liver disease"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38542753", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["842", "10.3390/nu16060842"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "15"}], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "16", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "15"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Ginsenoside Rg<sub>5</sub> Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet.", "Abstract": {"AbstractText": ["The primary objective of this investigation was to elucidate the manner in which ginsenoside Rg<sub>5</sub> (Rg<sub>5</sub>) ameliorates nonalcoholic fatty liver disease (NAFLD) via the modulation of the gut microbiota milieu. We administered either a standard diet (ND) or a high-fat diet (HFD), coupled with 12-week treatment employing two distinct doses of Rg<sub>5</sub> (50 and 100 mg/kg/d), to male C57BL/6J mice. In comparison to the HFD cohort, the Rg<sub>5</sub>-treated group demonstrated significant enhancements in biochemical parameters, exemplified by a substantial decrease in lipid concentrations, as well as the reduced expression of markers indicative of oxidative stress and liver injury. This signifies a mitigation of hepatic dysfunction induced by an HFD. Simultaneously, Rg<sub>5</sub> demonstrates the capacity to activate the LKB1/AMPK/mTOR signaling pathway, instigating energy metabolism and consequently hindering the progression of NAFLD. Furthermore, we underscored the role of Rg<sub>5</sub> in the treatment of NAFLD within the gut-microbiota-liver axis. Analysis via 16S rRNA sequencing unveiled that Rg<sub>5</sub> intervention induced alterations in gut microbiota composition, fostering an increase in beneficial bacteria, such as <i>Bacteroides</i> and <i>Akkermansia</i>, while concurrently reducing the relative abundance of detrimental bacteria, exemplified by <i>Olsenella</i>. Furthermore, employing fecal microbiota transplantation (FMT) experiments, we observed analogous outcomes in mice subjected to fecal bacterial transplants, providing additional verification of the capacity of Rg<sub>5</sub> to mitigate NAFLD in mice by actively participating in the restoration of gut microbiota via FMT. Drawing from these data, the regulation of the gut microbiota is recognized as an innovative strategy for treating or preventing NAFLD and metabolic syndrome. Consequently, these research findings suggest that Rg<sub>5</sub> holds promise as a potential therapeutic agent for NAFLD management."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China."}, {"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Shi", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Chen", "ForeName": "Jianbo", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Qu", "ForeName": "Di", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China."}, {"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Sun", "ForeName": "Qiang", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Yu", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China."}, {"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Zhang", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Liu", "ForeName": "Zhengbo", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Sha", "ForeName": "Jiyue", "Initials": "J"}, {"Identifier": ["0000-0002-1889-4984"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China."}, {"Identifier": [], "Affiliation": "Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun 130112, China."}], "LastName": "Sun", "ForeName": "Yinshi", "Initials": "Y"}], "GrantList": [{"GrantID": "2023YFD1601600", "Agency": "National Key Research and Development Program", "Country": ""}, {"GrantID": "2023QN16", "Agency": "Jilin Provincial Department of Human Resources and Social Security", "Country": ""}, {"GrantID": "202301ZYTS352", "Agency": "Jilin Province Science and Technology Development Program", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Ribosomal, 16S"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ginsenosides"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["metabolism"], "DescriptorName": "RNA, Ribosomal, 16S"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Bacteria"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Powell E.E., Wong V.W.S., Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u20132224. doi: 10.1016/S0140-6736(20)32511-3.", "ArticleIdList": ["10.1016/S0140-6736(20)32511-3", "33894145"]}, {"Citation": "Friedman S.L., Neuschwander-Tetri B.A., Rinella M., Sanyal A.J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 2018;24:908\u2013922. doi: 10.1038/s41591-018-0104-9.", "ArticleIdList": ["10.1038/s41591-018-0104-9", "PMC6553468", "29967350"]}, {"Citation": "Youssefian L., Vahidnezhad H., Saeidian A.H., Pajouhanfar S., Sotoudeh S., Mansouri P., Amirkashani D., Zeinali S., Levine M.A., Peris K., et al. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations. J. Hepatol. 2019;71:366\u2013370. doi: 10.1016/j.jhep.2019.03.026.", "ArticleIdList": ["10.1016/j.jhep.2019.03.026", "PMC7285838", "30954460"]}, {"Citation": "Aron-Wisnewsky J., Vigliotti C., Witjes J., Le P., Holleboom A.G., Verheij J., Nieuwdorp M., Cl\u00e9ment K. Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders. Nat. Rev. 2020;17:279\u2013297. doi: 10.1038/s41575-020-0269-9.", "ArticleIdList": ["10.1038/s41575-020-0269-9", "32152478"]}, {"Citation": "Liu J., Wu A., Cai J., She Z.-G., Li H. The contribution of the gut-liver axis to the immune signaling pathway of NAFLD. Front. Immunol. 2022;13:968799. doi: 10.3389/fimmu.2022.968799.", "ArticleIdList": ["10.3389/fimmu.2022.968799", "PMC9471422", "36119048"]}, {"Citation": "Makki K., Deehan E.C., Walter J., B\u00e4ckhed F. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. Cell Host Microbe. 2018;23:705\u2013715. doi: 10.1016/j.chom.2018.05.012.", "ArticleIdList": ["10.1016/j.chom.2018.05.012", "29902436"]}, {"Citation": "Roselli M., Natella F., Zinno P., Guantario B., Canali R., Schifano E., De Angelis M., Nikoloudaki O., Gobbetti M., Perozzi G., et al. Colonization ability and impact on hu-man gut microbiota of foodborne microbes from traditional or probiotic-added fermented foods: A systematic review. Front. Nutr. 2021;8:689084. doi: 10.3389/fnut.2021.689084.", "ArticleIdList": ["10.3389/fnut.2021.689084", "PMC8360115", "34395494"]}, {"Citation": "Vijay A., Valdes A.M. Role of the gut microbiome in chronic diseases: A narrative review. Eur. J. Clin. Nutr. 2022;76:489\u2013501. doi: 10.1038/s41430-021-00991-6.", "ArticleIdList": ["10.1038/s41430-021-00991-6", "PMC8477631", "34584224"]}, {"Citation": "Su Y., Li J., Wu L., Kuang H. Polysaccharides from TCM herbs exhibit potent anti-obesity effect by mediating the community structure of gut microbiota. Pharmazie. 2021;76:473\u2013479.", "ArticleIdList": ["34620273"]}, {"Citation": "Wu Z., Tian E., Chen Y., Dong Z., Peng Q. Gut microbiota and its roles in the pathogenesis and therapy of en-do-crine system diseases. Microbiol. Res. 2023;268:127291. doi: 10.1016/j.micres.2022.127291.", "ArticleIdList": ["10.1016/j.micres.2022.127291", "36542917"]}, {"Citation": "Blaak E.E., Canfora E.E., Theis S., Frost G., Groen A.K., Mithieux G., Nauta A., Scott K., Stahl B., Van Harsselaar J., et al. Short chain fatty acids in human gut and metabolic health. Benef. Microbes. 2020;11:411\u2013455. doi: 10.3920/BM2020.0057.", "ArticleIdList": ["10.3920/BM2020.0057", "32865024"]}, {"Citation": "Chen C., Lv Q., Li Y., Jin Y.H. The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells. Molecules. 2021;26:3926. doi: 10.3390/molecules26133926.", "ArticleIdList": ["10.3390/molecules26133926", "PMC8271777", "34199025"]}, {"Citation": "Wang J., Zhang X., Yang X., Yu H., Bu M., Fu J., Zhang Z., Xu H., Hu J., Lu J., et al. Revitalizing myocarditis treatment through gut microbiota modulation: Unveiling a promising therapeutic avenue. Front. Cell. Infect. Microbiol. 2023;13:1191936. doi: 10.3389/fcimb.2023.1191936.", "ArticleIdList": ["10.3389/fcimb.2023.1191936", "PMC10229058", "37260696"]}, {"Citation": "Gao P., Zheng M., Lu H., Lu S. The progressive utilization of ponkan peel residue for regulating human gut microbiota through sequential extraction and modification of its dietary fibers. Foods. 2023;12:4148. doi: 10.3390/foods12224148.", "ArticleIdList": ["10.3390/foods12224148", "PMC10670068", "38002205"]}, {"Citation": "Qian J., Lu J., Cheng S., Zou X., Tao Q., Wang M., Wang N., Zheng L., Liao W., Li Y., et al. Periodontitis salivary microbiota exacerbates colitis-induced anxiety-like behavior via gut microbiota. Npj Biofilms Microbiomes. 2023;9:93. doi: 10.1038/s41522-023-00462-9.", "ArticleIdList": ["10.1038/s41522-023-00462-9", "PMC10703887", "38062089"]}, {"Citation": "Bai Z., Huang X., Wu G., Ye H., Huang W., Nie Q., Chen H., Yin J., Chen Y., Nie S. Polysaccharides from red kidney bean alleviating hyperglycemia and hyperlipidemia in type 2 diabetic rats via gut microbiota and lipid metabolic modulation. Food Chem. 2023;404 Pt A:134598. doi: 10.1016/j.foodchem.2022.134598.", "ArticleIdList": ["10.1016/j.foodchem.2022.134598", "36444040"]}, {"Citation": "Bolyen E., Rideout J.R., Dillon M.R., Bokulich N.A., Abnet C.C., Al-Ghalith G.A., Alexander H., Alm E.J., Arumugam M., Asnicar F., et al. Reproducible, in-teractive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 2019;37:852\u2013857. doi: 10.1038/s41587-019-0209-9.", "ArticleIdList": ["10.1038/s41587-019-0209-9", "PMC7015180", "31341288"]}, {"Citation": "Bokulich N.A., Kaehler B.D., Rideout J.R., Dillon M., Bolyen E., Knight R., Huttley G.A., Gregory Caporaso J. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2032s q2-feature-classifier plugin. Microbiome. 2018;6:90. doi: 10.1186/s40168-018-0470-z.", "ArticleIdList": ["10.1186/s40168-018-0470-z", "PMC5956843", "29773078"]}, {"Citation": "Ren D.D., Chen K.C., Li S.S., Zhang Y.T., Li Z.M., Liu S., Sun Y.S. Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium. Front. Immunol. 2023;14:1161625. doi: 10.3389/fimmu.2023.1161625.", "ArticleIdList": ["10.3389/fimmu.2023.1161625", "PMC10321667", "37415978"]}, {"Citation": "Zheng Z., Lyu W., Ren Y., Li X., Zhao S., Yang H., Xiao Y. Allobaculum involves in the modulation of intestinal ANGPTLT4 expression in mice treated by high-fat diet. Front. Nutr. 2021;8:690138. doi: 10.3389/fnut.2021.690138.", "ArticleIdList": ["10.3389/fnut.2021.690138", "PMC8171929", "34095196"]}, {"Citation": "Zhang D., Jian Y.P., Zhang Y.N., Li Y., Gu L.T., Sun H.H., Liu M.D., Zhou H.L., Wang Y.S., Xu Z.X. Short-chain fatty acids in diseases. Cell Commun. Signal. CCS. 2023;21:212. doi: 10.1186/s12964-023-01219-9.", "ArticleIdList": ["10.1186/s12964-023-01219-9", "PMC10436623", "37596634"]}, {"Citation": "Han H., Jiang Y., Wang M., Melaku M., Liu L., Zhao Y., Everaert N., Yi B., Zhang H. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): Focusing on the gut-liver axis. Crit. Rev. Food Sci. Nutr. 2023;63:1689\u20131706. doi: 10.1080/10408398.2021.1966738.", "ArticleIdList": ["10.1080/10408398.2021.1966738", "34404276"]}, {"Citation": "Everard A., Lazarevic V., Ga\u00efa N., Johansson M., St\u00e5hlman M., Backhed F., Delzenne N.M., Schrenzel J., Fran\u00e7ois P., Cani P.D. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014;8:2116\u20132130. doi: 10.1038/ismej.2014.45.", "ArticleIdList": ["10.1038/ismej.2014.45", "PMC4163056", "24694712"]}, {"Citation": "Bao T., He F., Zhang X., Zhu L., Wang Z., Lu H., Wang T., Li Y., Yang S., Wang H. Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccha-ride-toll-like receptor 4-M\u03c8-nuclear factor-\u03baB-nod-Like receptor protein 3 pathway via gut-liver axis in mice. Front. Pharmacol. 2020;11:558525. doi: 10.3389/fphar.2020.558525.", "ArticleIdList": ["10.3389/fphar.2020.558525", "PMC7774311", "33390939"]}, {"Citation": "Yu M., Li Z., Chen W., Rong T., Wang G., Ma X. Microbiome-metabolomics analysis investigating the impacts of dietary starch types on the composition and metabolism of colonic microbiota in finishing pigs. Front. Microbiol. 2019;10:1143. doi: 10.3389/fmicb.2019.01143.", "ArticleIdList": ["10.3389/fmicb.2019.01143", "PMC6549541", "31191480"]}, {"Citation": "Csala A., Hof M.H., Zwinderman A.H. Multiset sparse redundancy analysis for high-dimensional omics data. Biom. J. 2019;61:406\u2013423. doi: 10.1002/bimj.201700248.", "ArticleIdList": ["10.1002/bimj.201700248", "PMC6587877", "30506971"]}, {"Citation": "Xie Z., Du J., Gan M., Zhou C., Li M., Liu C., Wang M., Chen L., Zhao Y., Wang Y. Short-term dietary choline supplementation alters the gut microbiota and liver metabolism of finishing pigs. Front. Microbiol. 2023;14:1266042. doi: 10.3389/fmicb.2023.1266042.", "ArticleIdList": ["10.3389/fmicb.2023.1266042", "PMC10569418", "37840732"]}, {"Citation": "Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384. doi: 10.1002/hep.28431.", "ArticleIdList": ["10.1002/hep.28431", "26707365"]}, {"Citation": "Jin W., Li C., Yang S., Song S., Hou W., Song Y., Du Q. Hypolipidemic effect and molecular mechanism of ginsenosides: A review based on oxidative stress. Front. Pharmacol. 2023;14:1166898. doi: 10.3389/fphar.2023.1166898.", "ArticleIdList": ["10.3389/fphar.2023.1166898", "PMC10175615", "37188264"]}, {"Citation": "Liang W., Zhou K., Jian P., Chang Z., Zhang Q., Liu Y., Xiao S., Zhang L. Ginsenosides improve nonalcoholic fatty liver disease via integrated regulation of gut microbiota, inflammation and energy homeostasis. Front. Pharmacol. 2021;12:622841. doi: 10.3389/fphar.2021.622841.", "ArticleIdList": ["10.3389/fphar.2021.622841", "PMC7928318", "33679403"]}, {"Citation": "Zhu Y., Zhu C., Yang H., Deng J., Fan D. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Pharmacol. Res. 2020;155:104746. doi: 10.1016/j.phrs.2020.104746.", "ArticleIdList": ["10.1016/j.phrs.2020.104746", "32156650"]}, {"Citation": "Liu M.Y., Liu F., Gao Y.L., Yin J.N., Yan W.Q., Liu J.G., Li H.J. Pharmacological activities of ginsenoside Rg5 (Review) Exp. Ther. Med. 2021;22:840. doi: 10.3892/etm.2021.10272.", "ArticleIdList": ["10.3892/etm.2021.10272", "PMC8210315", "34149886"]}, {"Citation": "Xiao N., Lou M.D., Lu Y.T., Yang L.L., Liu Q., Liu B., Qi L.W., Li P. Ginsenoside Rg5 attenuates hepatic glucagon response via suppression of succinate-associated HIF-1\u03b1 induction in HFD-fed mice. Diabetologia. 2017;60:1084\u20131093. doi: 10.1007/s00125-017-4238-y.", "ArticleIdList": ["10.1007/s00125-017-4238-y", "28280902"]}, {"Citation": "Wei Y., Yang H., Zhu C., Deng J., Fan D. Hypoglycemic Effect of Ginsenoside Rg5 Mediated Partly by Modulating Gut Microbiota Dysbiosis in Diabetic db/db Mice. J. Agric. Food Chem. 2020;68:5107\u20135117. doi: 10.1021/acs.jafc.0c00605.", "ArticleIdList": ["10.1021/acs.jafc.0c00605", "32307991"]}, {"Citation": "Li N., Zhu C., Fu R., Ma X., Duan Z., Fan D. Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice. Phytomedicine. 2024;124:155287. doi: 10.1016/j.phymed.2023.155287.", "ArticleIdList": ["10.1016/j.phymed.2023.155287", "38176268"]}, {"Citation": "Garcia D., Shaw R.J. AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell. 2017;66:789\u2013800. doi: 10.1016/j.molcel.2017.05.032.", "ArticleIdList": ["10.1016/j.molcel.2017.05.032", "PMC5553560", "28622524"]}, {"Citation": "Xiong Y., Xu Z., Wang Y., Kuang S., Shan T. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance. J. Lipid Res. 2018;59:974\u2013981. doi: 10.1194/jlr.M081463.", "ArticleIdList": ["10.1194/jlr.M081463", "PMC5983395", "29636366"]}, {"Citation": "Panwar V., Singh A., Bhatt M., Tonk R.K., Azizov S., Raza A.S., Sengupta S., Kumar D., Garg M. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct. Target. Ther. 2023;8:375. doi: 10.1038/s41392-023-01608-z.", "ArticleIdList": ["10.1038/s41392-023-01608-z", "PMC10543444", "37779156"]}, {"Citation": "Saxton R.A., Sabatini D.M. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168:960\u2013976. doi: 10.1016/j.cell.2017.02.004.", "ArticleIdList": ["10.1016/j.cell.2017.02.004", "PMC5394987", "28283069"]}, {"Citation": "Zhu W., Zhou Y., Tsao R., Dong H., Zhang H. Amelioratory effect of resistant starch on non-alcoholic fatty liver disease via the gut-liver axis. Front. Nutr. 2022;9:861854. doi: 10.3389/fnut.2022.861854.", "ArticleIdList": ["10.3389/fnut.2022.861854", "PMC9159374", "35662935"]}, {"Citation": "Zhang Q., Xing W., Wang Q., Tang Z., Wang Y., Gao W. Gut microbiota-mitochondrial inter-talk in nonalcoholic fatty liver disease. Front. Nutr. 2022;9:934113. doi: 10.3389/fnut.2022.934113.", "ArticleIdList": ["10.3389/fnut.2022.934113", "PMC9530335", "36204383"]}, {"Citation": "Hrncir T., Hrncirova L., Kverka M., Hromadka R., Machova V., Trckova E., Kostovcikova K., Kralickova P., Krejsek J., Tlaskalova-Hogenova H. Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms. 2021;9:957. doi: 10.3390/microorganisms9050957.", "ArticleIdList": ["10.3390/microorganisms9050957", "PMC8146698", "33946843"]}, {"Citation": "Plaza-D\u00edaz J., Solis-Urra P., Arag\u00f3n-Vela J., Rodr\u00edguez-Rodr\u00edguez F., Olivares-Arancibia J., \u00c1lvarez-Mercado A.I. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines. 2021;9:145. doi: 10.3390/biomedicines9020145.", "ArticleIdList": ["10.3390/biomedicines9020145", "PMC7913217", "33546191"]}, {"Citation": "Rodr\u00edguez-Daza M.C., Pulido-Mateos E.C., Lupien-Meilleur J., Guyonnet D., Desjardins Y., Roy D. Polyphenolmediated gut microbiota modulation: Toward prebiotics and further. Front. Nutr. 2021;8:689456. doi: 10.3389/fnut.2021.689456.", "ArticleIdList": ["10.3389/fnut.2021.689456", "PMC8276758", "34268328"]}, {"Citation": "Yin J., Li Y., Han H., Ma J., Liu G., Wu X., Huang X., Fang R., Baba K., Bin P. Administration of exogenous melatonin improves the diurnal rhythms of the gut microbiota in mice fed a high-fat diet. mSystems. 2020;5:e00002-20. doi: 10.1128/mSystems.00002-20.", "ArticleIdList": ["10.1128/mSystems.00002-20", "PMC7253360", "32430404"]}, {"Citation": "Yang J., Li Y., Wen Z., Liu W., Meng L., Huang H. Oscillospira-A candidate for the next-generation probiotics. Gut Microbes. 2021;13:1987783. doi: 10.1080/19490976.2021.1987783.", "ArticleIdList": ["10.1080/19490976.2021.1987783", "PMC8547878", "34693878"]}, {"Citation": "Carvalho B.M., Guadagnini D., Tsukumo D.M.L., Schenka A.A., Latuf-Filho P., Vassallo J., Dias J.C., Kubota L.T., Carvalheira J.B.C., Saad M.J.A. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia. 2012;55:2823\u20132834. doi: 10.1007/s00125-012-2648-4.", "ArticleIdList": ["10.1007/s00125-012-2648-4", "22828956"]}, {"Citation": "Depommier C., Everard A., Druart C., Plovier H., Van Hul M., Vieira-Silva S., Falony G., Raes J., Maiter D., Delzenne N.M., et al. Supplementation with Ak-ker-mansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat. Med. 2019;25:1096\u20131103. doi: 10.1038/s41591-019-0495-2.", "ArticleIdList": ["10.1038/s41591-019-0495-2", "PMC6699990", "31263284"]}, {"Citation": "van Muijlwijk G.H., van Mierlo G., Jansen P.W.T.C., Vermeulen M., Bleumink-Pluym N.M.C., Palm N.W., van Putten J.P.M., de Zoete M.R. Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. Gut Microbes. 2021;13:1966278. doi: 10.1080/19490976.2021.1966278.", "ArticleIdList": ["10.1080/19490976.2021.1966278", "PMC8409761", "34455931"]}, {"Citation": "Hong Y., Sheng L., Zhong J., Tao X., Zhu W., Ma J., Yan J., Zhao A., Zheng X., Wu G. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Gut Microbes. 2021;13:1930874. doi: 10.1080/19490976.2021.1930874.", "ArticleIdList": ["10.1080/19490976.2021.1930874", "PMC8205104", "34125646"]}, {"Citation": "Zikou E., Dovrolis N., Dimosthenopoulos C., Gazouli M., Makrilakis K. The effect of probiotic supplements on metabolic parameters of people with type 2 diabetes in greece-a randomized, double-blind, placebo-controlled study. Nutrients. 2023;15:4663. doi: 10.3390/nu15214663.", "ArticleIdList": ["10.3390/nu15214663", "PMC10647535", "37960315"]}, {"Citation": "Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., Almeida M., Quinquis B., Levenez F., Galleron N., et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;500:585\u2013588. doi: 10.1038/nature12480.", "ArticleIdList": ["10.1038/nature12480", "23985875"]}, {"Citation": "Xue L., Deng Z., Luo W., He X., Chen Y. Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial. Front. Cell. Infect. Microbiol. 2022;12:759306. doi: 10.3389/fcimb.2022.759306.", "ArticleIdList": ["10.3389/fcimb.2022.759306", "PMC9289257", "35860380"]}, {"Citation": "Tariq R., Syed T., Yadav D., Prokop L.J., Singh S., Loftus E.V., Jr., Pardi D.S., Khanna S. Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: A systematic review and meta-analysis. J. Clin. Gastroenterol. 2023;57:285\u2013293. doi: 10.1097/MCG.0000000000001633.", "ArticleIdList": ["10.1097/MCG.0000000000001633", "34864789"]}, {"Citation": "Coia H., Ma N., Hou Y., Dyba M.D., Fu Y., Cruz M.I., Benitez C., Graham G.T., McCutcheon J.N., Zheng Y.L., et al. Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev. Res. 2018;11:665\u2013676. doi: 10.1158/1940-6207.CAPR-18-0160.", "ArticleIdList": ["10.1158/1940-6207.CAPR-18-0160", "PMC6171362", "30131435"]}, {"Citation": "Guo J., Pereira T.J., Dalvi P., Yeung L.S.N., Swain N., Breen D.M., Lam L., Dolinsky V.W., Giacca A. High-dose metformin (420 mg/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis. Metabolism. 2016;68:108\u2013118. doi: 10.1016/j.metabol.2016.12.002.", "ArticleIdList": ["10.1016/j.metabol.2016.12.002", "28183442"]}, {"Citation": "Norris G.H., Porter C.M., Jiang C., Millar C.L., Blesso C.N. Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. J. Nutr. Biochem. 2017;40:36\u201343. doi: 10.1016/j.jnutbio.2016.09.017.", "ArticleIdList": ["10.1016/j.jnutbio.2016.09.017", "27855315"]}, {"Citation": "Tordoff M.G., Aleman T.R., Murphy M.C. No effects of monosodium glutamate consumption on the body weight or composition of adult rats and mice. Physiol. Behav. 2012;107:338\u2013345. doi: 10.1016/j.physbeh.2012.07.006.", "ArticleIdList": ["10.1016/j.physbeh.2012.07.006", "22868067"]}, {"Citation": "Lee Y.J., Ko E.H., Kim J.E., Kim E., Lee H., Choi H., Yu J.H., Kim H.J., Seong J.K., Kim K.S., et al. Nuclear receptor PPAR\u03b3-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc. Natl. Acad. Sci. USA. 2012;109:13656\u201313661. doi: 10.1073/pnas.1203218109.", "ArticleIdList": ["10.1073/pnas.1203218109", "PMC3427113", "22869740"]}, {"Citation": "Perry R.J., Resch J.M., Douglass A.M., Madara J.C., Rabin-Court A., Kucukdereli H., Wu C., Song J.D., Lowell B.B., Shulman G.I. Leptin\u2019s hunger-suppressing effects are mediated by the hypothalamic\u2013pituitary\u2013adrenocortical axis in rodents. ESPE Yearb. Paediatr. Endocrinol. 2020;17 doi: 10.1073/pnas.1901795116.", "ArticleIdList": ["10.1073/pnas.1901795116", "PMC6613139", "31213533"]}, {"Citation": "Miranda C.L., Johnson L.A., de Montgolfier O., Elias V.D., Ullrich L.S., Hay J.J., Paraiso I.L., Choi J., Reed R.L., Revel J.S., et al. Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice. Sci. Rep. 2018;8:1\u201317. doi: 10.1038/s41598-017-18992-6.", "ArticleIdList": ["10.1038/s41598-017-18992-6", "PMC5766630", "29330372"]}, {"Citation": "Mitchell S.J., Bernier M., Aon M.A., Cortassa S., Kim E.Y., Fang E.F., Palacios H.H., Ali A., Navas-Enamorado I., Di Francesco A., et al. Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice. Cell Metab. 2018;27:667\u2013676.e4. doi: 10.1016/j.cmet.2018.02.001.", "ArticleIdList": ["10.1016/j.cmet.2018.02.001", "PMC5854409", "29514072"]}, {"Citation": "Kopec A.K., Abrahams S.R., Thornton S., Palumbo J.S., Mullins E.S., Divanovic S., Weiler H., Owens A.P., 3rd, Mackman N., Goss A., et al. Thrombin promotes diet-induced obesity through fibrin-driven inflammation. J. Clin. Investig. 2017;127:3152\u20133166. doi: 10.1172/JCI92744.", "ArticleIdList": ["10.1172/JCI92744", "PMC5531415", "28737512"]}, {"Citation": "Yang J.W., Kim H.S., Im J.H., Kim J.W., Jun D.W., Lim S.C., Lee K., Choi J.M., Kim S.K., Kang K.W. GPR119: A promising target for nonalcoholic fatty liver disease. FASEB J. 2016;30:324\u2013335. doi: 10.1096/fj.15-273771.", "ArticleIdList": ["10.1096/fj.15-273771", "26399788"]}, {"Citation": "Miyao M., Kotani H., Ishida T., Kawai C., Manabe S., Abiru H., Tamaki K. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Mod. Pathol. 2015;95:1130\u20131144. doi: 10.1038/labinvest.2015.95.", "ArticleIdList": ["10.1038/labinvest.2015.95", "26214582"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "29"}, {"Year": "2024", "Month": "3", "Day": "5"}, {"Year": "2024", "Month": "3", "Day": "9"}, {"Year": "2024", "Month": "3", "Day": "29", "Hour": "6", "Minute": "46"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "1", "Minute": "21"}, {"Year": "2024", "Month": "3", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["38542753", "PMC10974897", "10.3390/nu16060842", "nu16060842"]}}]}